This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Elanco Animal Health (ELAN) and Align Tech (ALGN)

Tipranks - Tipranks - Tue May 12, 8:28AM CDT

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Definitive Healthcare Corp (DH), Elanco Animal Health (ELAN) and Align Tech (ALGN).

Claim 55% Off TipRanks

Definitive Healthcare Corp (DH)

In a report issued on May 8, David Hynes from Canaccord Genuity maintained a Hold rating on Definitive Healthcare Corp, with a price target of $3.00. The company’s shares closed last Friday at $0.95.

According to TipRanks.com, Hynes has 0 stars on 0-5 stars ranking scale with an average return of -12.1% and a 33.0% success rate. Hynes covers the Technology sector, focusing on stocks such as ServiceTitan, Inc. Class A, Zeta Global Holdings Corp, and Klaviyo, Inc. Class A. ;'>

Definitive Healthcare Corp has an analyst consensus of Hold, with a price target consensus of $2.51, implying a 139.0% upside from current levels. In a report issued on May 9, TipRanks – PerPlexity also upgraded the stock to Hold with a $0.95 price target.

See the top stocks recommended by analysts >>

Elanco Animal Health (ELAN)

Evercore ISI analyst Umer Raffat maintained a Buy rating on Elanco Animal Health today. The company’s shares closed last Friday at $23.65.

According to TipRanks.com, Raffat is a 4-star analyst with an average return of 8.6% and a 48.2% success rate. Raffat covers the Healthcare sector, focusing on stocks such as Centessa Pharmaceuticals, Bausch Health Companies, and Atea Pharmaceuticals. ;'>

Currently, the analyst consensus on Elanco Animal Health is a Strong Buy with an average price target of $29.27, implying a 21.2% upside from current levels. In a report issued on May 9, TipRanks – Google also upgraded the stock to Buy with a $26.00 price target.

Align Tech (ALGN)

In a report released today, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on Align Tech, with a price target of $220.00. The company’s shares closed last Friday at $168.78, close to its 52-week low of $157.57.

According to TipRanks.com, CFA has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -3.3% and a 43.8% success rate. CFA covers the Healthcare sector, focusing on stocks such as Hinge Health, Inc. Class A, Fortrea Holdings Inc., and Privia Health Group. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Align Tech with a $203.27 average price target, a 20.7% upside from current levels. In a report issued on April 30, TipRanks – PerPlexity also upgraded the stock to Buy with a $200.00 price target.

Read More on DH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).